Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer

Publisher: Bentham Science Publishers

E-ISSN: 2212-6988|1|2|127-148

ISSN: 2212-697x

Source: Clinical Cancer Drugs, Vol.1, Iss.2, 2014-05, pp. : 127-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract